Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

  Ron T. Gansevoort ¹ AuthorId : 1286249
Author

  Mustafa Arici ² AuthorId : 1286250
Author

  Thomas Benzing ^{3, 4} AuthorId : 425800
Author

  Henrik Birn ^{5, 6} AuthorId : 1286251
Author

  Giovambattista Capasso AuthorId : 1286252
Author

  Adrian Covic ⁷ AuthorId : 1286253
Author

  Olivier Devuyst ^{8, 9, 10} AuthorId : 485318
Author

  Christiane Drechsler ¹¹ AuthorId : 1286254
Author

  Kai-Uwe Eckardt ¹² AuthorId : 1286255
Author

  Francesco Emma ¹³ AuthorId : 957366
Author

  Bertrand Knebelmann ¹⁴ AuthorId : 1243947
Author

  Yannick Le Meur ^{15, 16} AuthorId : 367808
Author

  Ziad A. Massy ^{17, 18, 19} AuthorId : 1286256
Author

  Albert C.M. Ong ²⁰ AuthorId : 1286257
Author

  Alberto Ortiz ^{21, 22, 23} AuthorId : 1281634
Author

  Franz Schaefer ²⁴ AuthorId : 957369
Author

  Roser Torra ^{25, 26} AuthorId : 1286258
Author

  Raymond Vanholder ²⁷ AuthorId : 827230
Author

  Andrzej Więcek ^{25, 28} AuthorId : 1286259
Author

  Carmine Zoccali ²⁹ AuthorId : 1286260
Author

  Wim van Biesen ³⁰ AuthorId : 1286261
Author